AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2021
Jan 14, 2021
33298_dirs_2021-01-14_fa44e338-d98f-4ecc-8a97-59b6087dc9ba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2020-01-05
Reporting Person: Hussey Bryant Patrick (Chief Digital Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options to purchase shares of Common Stock | $ | Common Stock, par value $0.001 (200000) | Direct |
Footnotes
F1: Pursuant to the terms of the employment agreement, by and between Mr. Hussey and the Issuer, on January 8, 2021 (the "Effective Date"), Mr. Hussey was granted stock options to purchase up to 200,000 shares of the Company's common stock at an exercise price of $7.50 per share (the "Stock Options"). The Stock Options are scheduled to vest in equal monthly tranches, based on the passage of time, over the 36 months following the approval of the Effective Date.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17